Laura Vaingard

Laura Vaingard

Public Policy Expert
Laura Vaingard offers insights on healthcare reform for public policy professionals,  suggesting various interventions government officials can implement nationally to alleviate poor healthcare practices. She advocates for healthcare reform for rural communities and expanded access to mental health services, while also discussing the economics of prescription drug pricing.
How Is Regional Competition Modernizing Spain’s Healthcare?
Public Policy How Is Regional Competition Modernizing Spain’s Healthcare?

The decentralized nature of the Spanish National Health System has transformed the country into a living laboratory where seventeen autonomous regions compete to define the future of medical care through digital innovation. This fragmentation, once viewed as a bureaucratic hurdle, is now the

PeaceHealth Deal Tests Oregon Law on Corporate Medicine
Public Policy PeaceHealth Deal Tests Oregon Law on Corporate Medicine

The landscape of healthcare in the Pacific Northwest is currently grappling with a fundamental identity crisis as nonprofit systems attempt to balance their charitable missions with the unforgiving realities of modern labor economics. At the center of this storm is PeaceHealth, a major Catholic

New York Seeks Reform to Lower Rising Healthcare Costs
Public Policy New York Seeks Reform to Lower Rising Healthcare Costs

The staggering financial reality of New York’s medical landscape has reached a critical juncture where the cost of a single procedure can fluctuate by tens of thousands of dollars based solely on which side of a county line a hospital sits. As the state grapples with its position at the bottom of t

New Mexico Governor Signs Major Healthcare Reform Laws
Public Policy New Mexico Governor Signs Major Healthcare Reform Laws

The architectural skeleton of the new Valencia County Hospital in Los Lunas served as more than just a backdrop this week; it stood as a tangible symbol of a state finally aggressive enough to overhaul its own survival mechanisms. Governor Michelle Lujan Grisham has officially signed a suite of

Is Preventive Care the Future of Malaysia’s Healthcare?
Public Policy Is Preventive Care the Future of Malaysia’s Healthcare?

For decades, the success of the Malaysian medical system was measured by the sheer height of its hospital towers and the number of specialized beds available to the public. This long-standing obsession with physical infrastructure has created a paradox where a world-class reactive system struggles

The Crisis of U.S. Healthcare Reform and Market Failures
Public Policy The Crisis of U.S. Healthcare Reform and Market Failures

The American healthcare infrastructure currently stands at a precarious crossroads where the relentless escalation of delivery costs threatens to destabilize the broader national economy while political attention remains diverted by international volatility. This multi-trillion-dollar industry has

FDA Approves Zongertinib for HER2-Mutant Lung Cancer
Public Policy FDA Approves Zongertinib for HER2-Mutant Lung Cancer

Precision Oncology and the Evolution of Targeted Lung Cancer Therapies The landscape of thoracic oncology has shifted dramatically as pharmaceutical innovation increasingly focuses on the granular genetic drivers that dictate tumor behavior in non-small cell lung cancer. This evolution marks a

Can San Diego Safeguard Healthcare Against Federal Cuts?
Public Policy Can San Diego Safeguard Healthcare Against Federal Cuts?

The Regional Healthcare Landscape and the CMS Safety Net The resilience of a regional healthcare system is currently being tested by a legislative shift that threatens to dismantle the foundational support for the most vulnerable citizens of San Diego. Unlike many other major metropolitan areas in

UK Proposes Indefinite CE Mark Recognition for Medical Devices
Public Policy UK Proposes Indefinite CE Mark Recognition for Medical Devices

Navigating the Post-Brexit Medical Technology Landscape in Great Britain The global medical technology market stands at a critical crossroads where the friction of regulatory boundaries often dictates the pace of life-saving innovation. The United Kingdom's recent policy shifts signal a

FDA Approves Yuviwel for Weekly Treatment of Achondroplasia
Public Policy FDA Approves Yuviwel for Weekly Treatment of Achondroplasia

The recent authorization of Yuviwel by the FDA represents a transformative moment for thousands of families navigating the complexities of achondroplasia, effectively dismantling a long-standing market monopoly. For the first time, pediatric patients aged two and older with open growth plates have

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later